Mercer Global Advisors
GNLX icon

Mercer Global Advisors’s Genelux GNLX Stock Holding History

Mercer Global Advisors’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,750
Closed -$30.9K – 2679
2025
Q2 		$30.9K Hold
10,750
– – ﹤0.01% 2213
2025
Q1 		$29K Buy
+10,750
New +$40.3K ﹤0.01% 2121

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
PWM
Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Mercer Global Advisors's GNLX Position: Q3 2025 in Review

Mercer Global Advisors sold out of Genelux (GNLX) in Q3 2025, closing a stake of 10,750 shares — an estimated $30.9K sold.

Mercer Global Advisors first reported a position in GNLX in Q1 2025 and held it in 2 quarters. The position peaked at $30.9K in Q2 2025. 57 funds tracked by Wall St. Rank hold GNLX as of Q3 2025.

  • Mercer Global Advisors reported no remaining Genelux position as of Q3 2025 after selling out during the quarter.
  • Mercer Global Advisors sold 10,750 Genelux shares in Q3 2025, an estimated $30.9K.
  • Mercer Global Advisors first reported a position in Genelux in Q1 2025 and held it in 2 quarters.
  • Mercer Global Advisors's Genelux position peaked at $30.9K in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Genelux as of Q3 2025.

Based on Mercer Global Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.